Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ezetimibe/pitavastatin - Kowa

Next Previous
Drug Profile

Ezetimibe/pitavastatin - Kowa

Alternative Names: K 924; Pitavastatin 2mg/Ezetimibe 10mg tablets; Pitavastatin/Ezetimibe

Latest Information Update: 04 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kowa
  • Class Antihyperlipidaemics; Azetidines; Carboxylic acids; Cyclopropanes; Fluorobenzenes; Propanols; Quinolines; Small molecules
  • Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors; NPC1L1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Dyslipidaemias; Hypercholesterolaemia

Most Recent Events

  • 10 Mar 2025 Preregistration for Dyslipidaemias in Hong Kong, Malaysia, Singapore, Thailand (PO) (Kowa pipeline, March 2025)
  • 01 Oct 2023 Preregistration for Hypercholesterolaemia (In the elderly, In adults) in Taiwan (PO) (Kowa Pharmaceutical pipeline, October 2023)
  • 31 Dec 2021 Preregistration for Hypercholesterolaemia (In the elderly, In adults) in Japan (PO) (Kowa pipeline, December 2021)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top